01 23Sanofi-Aventis Canada Inc.
01 32378431
02 12685638
03 12740685
04 32780043
05 12780460
06 22835259
07 32835265
08 32835496
09 22846413
10 32851690
11 13011480
01 9INSULIN GLARGINE | LIXISENATIDE
02 14LIXISENATIDE
01 23SOLUTION
01 32020-07-12
02 12029-10-09
03 12029-11-13
04 52030-11-11
05 82032-05-11
06 22032-08-27
07 32032-10-26
Patent Expiration Date : 2020-07-12
Date Granted : 2010-02-09
Brand Name : ADLYXINE
Patent Number : 2378431
Filing Date : 2000-07-12
Strength per Unit : 0.1 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2020-07-12
Date Granted : 2010-02-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-11
Date Granted : 2019-01-29
Brand Name : ADLYXINE
Patent Number : 2780043
Filing Date : 2010-11-11
Strength per Unit : 0.1 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2030-11-11
Date Granted : 2019-01-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-05-11
Date Granted : 2020-01-07
Brand Name : ADLYXINE
Patent Number : 2835259
Filing Date : 2012-05-11
Strength per Unit : 0.1 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-05-11
Date Granted : 2020-01-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2020-07-12
Date Granted : 2010-02-09
Brand Name : ADLYXINE
Patent Number : 2378431
Filing Date : 2000-07-12
Strength per Unit : 0.05 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2020-07-12
Date Granted : 2010-02-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-11
Date Granted : 2019-01-29
Brand Name : ADLYXINE
Patent Number : 2780043
Filing Date : 2010-11-11
Strength per Unit : 0.05 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2030-11-11
Date Granted : 2019-01-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-05-11
Date Granted : 2020-01-07
Brand Name : ADLYXINE
Patent Number : 2835259
Filing Date : 2012-05-11
Strength per Unit : 0.05 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-05-11
Date Granted : 2020-01-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-10-09
Date Granted : 2018-09-11
INSULIN GLARGINE, LIXISENATIDE
Brand Name : SOLIQUA
Patent Number : 2740685
Filing Date : 2009-10-09
Strength per Unit : 100 units / mL / 33 mcg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-10-09
Date Granted : 2018-09-11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-11
Date Granted : 2018-09-04
INSULIN GLARGINE, LIXISENATIDE
Brand Name : SOLIQUA
Patent Number : 2780460
Filing Date : 2010-11-11
Strength per Unit : 100 units / mL / 33 mcg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2030-11-11
Date Granted : 2018-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-11
Date Granted : 2019-01-29
INSULIN GLARGINE, LIXISENATIDE
Brand Name : SOLIQUA
Patent Number : 2780043
Filing Date : 2010-11-11
Strength per Unit : 100 units / mL / 33 mcg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2030-11-11
Date Granted : 2019-01-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2020-07-12
Date Granted : 2010-02-09
INSULIN GLARGINE, LIXISENATIDE
Brand Name : SOLIQUA
Patent Number : 2378431
Filing Date : 2000-07-12
Strength per Unit : 100 units / mL / 33 mcg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2020-07-12
Date Granted : 2010-02-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
